Vaccine News and Research

Latest Vaccine News and Research

Latin America accounts for two-thirds of all confirmed H1N1 deaths

Health officials are growing increasingly concerned over the impact the H1N1 (swine) flu is having on populations living in Latin America, a region "which accounts for around two-thirds of the 816 confirmed deaths so far from the disease," the AFP/channelnewsasia.com reports. "The outlook is especially unsettling for the estimated 380 million people grappling with winter in South America, where the A(H1N1) virus is speedily propagating," the news service writes.

29 Jul 2009

Malaria vaccine in the pipeline

Australian scientists have developed the first genetically-engineered malaria vaccine and the vaccine will be trialled in humans early next year.

29 Jul 2009

Swine Flu - getting drugs to the market more rapidly

The pharmaceutical industry has been up in arms this year. Giants such as Pfizer, GSK and AstraZeneca are looking for deals in the downturn whilst competing against increasing generic competition as some of the best selling medicines are coming off patent. In addition to the sectors ever-changing landscape companies are under tremendous pressure from governments to combat the Swine flu pandemic that has gripped the world.

29 Jul 2009

Children needed for Australian swine flu vaccine trial

The child vaccine is similar to the adult one and two types of dose strengths and amounts will be tested in order to determine the correct dosage and the safety of the vaccine - it will be tested on children aged between six months and eight years in Melbourne, Adelaide, Perth, Sydney and Brisbane.

28 Jul 2009

World's first genetically-modified strain of malaria parasite

Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.

28 Jul 2009

H1N1 could infect up to 2 billion people within next two years, WHO says

The WHO on Friday said the "H1N1 swine-flu virus could infect up to two billion people over the next two years - about one of every three people in the world," VOA News reports.

28 Jul 2009

Asian pneumonia prevention organization calls for required pneumonia vaccine in India

The Asian Strategic Alliance for Pneumococcal Disease Prevention (ASAP) is calling for the pneumonia vaccine to become an official part of India's required list of immunizations, the Times of India reports.

28 Jul 2009

Gates Foundation donates additional $80 million to Indian HIV-prevention program, receives Indira Gandhi Prize for Peace, Disarmament and Development

The Bill & Melinda Gates Foundation will give an additional $80 million to Avahan, a foundation initiative launched in 2003 for HIV prevention programs in India, Bill Gates said on Thursday, the Seattle Times blog, "Business of Giving" reports.

28 Jul 2009

Age-prioritized use of antivirals during an influenza pandemic

A model of influenza transmission and treatment suggests that, if the current swine flu pandemic behaves like the 1918 flu, antiviral treatment should be reserved for the young.

27 Jul 2009

Potential malaria transmission-blocking vaccine

Researchers at the Johns Hopkins Malaria Research Institute have for the first time produced a malarial protein (Pfs48/45) in the proper conformation and quantity to generate a significant immune response in mice and non-human primates for use in a potential transmission-blocking vaccine.

26 Jul 2009

Global health officials working to prevent H1N1 spread

"Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with U.S. officials moving Thursday with a recommendation that the Food and Drug Administration (FDA) approve or license a [new H1N1] vaccine," without waiting on the results from "clinical trials to test its safety and efficacy," Wall Street Journal reports (Dooren/Winning, 7/24).

24 Jul 2009

FDA authorizes emergency use of another test for H1N1 flu virus

The U.S. Food and Drug Administration today announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization.

24 Jul 2009

Johns Hopkins-designed animal tuberculosis "tracker" to speed drug and vaccine studies

Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans.

23 Jul 2009

Brits get direct access to a pandemic flu service

Brits will soon have direct access to a pandemic flu service which will make drugs for swine flu available without needing to consult a doctor.

22 Jul 2009

Prevention, vaccines addressed at IAS conference

During the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention meeting in Cape Town, South Africa, scientists "renewed the call for more immediate and urgent effort to be directed towards HIV prevention amid the dominance of treatment interventions and the world-wide search for a quick fix vaccine, which many agree, is years away," Health-e/allAfrica.com reports (Thom, 7/22).

22 Jul 2009

H1N1 death toll doubles over last month; first vaccine trial begins

The worldwide death toll from the H1N1 (swine flu) virus has doubled in the past month, reaching over 700, the WHO announced Tuesday, the AP/Google.com reports.

22 Jul 2009

Swine flu vaccine trials begin in Australia as death toll tops 700

As Australian scientists embark on the first trials of a swine flu vaccine the World Health Organisation (WHO) has announced that the H1N1 virus (swine flu) has now killed more than 700 people around the world since the outbreak began four months ago.

22 Jul 2009

NovaSterilis receives patent for vaccine creation using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology for biomedical applications, announces the issue of US Patent 7,560,113 for creation and production of whole cell vaccines with supercritical carbon dioxide (SCCO2)*.

22 Jul 2009

NIAID to launch 2009 H1N1 influenza vaccine trials

Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

22 Jul 2009

South Africa launches HIV/AIDS vaccine trial

"The first clinical trial of an HIV/AIDS vaccine designed and developed in South Africa was launched in Cape Town" Monday, the SAPA/The Times reports.

20 Jul 2009